Search Results - "Verhoeff, Joost J C"

From algorithms to action: improving patient care requires causality by van Amsterdam, Wouter A C, de Jong, Pim A, Verhoeff, Joost J C, Leiner, Tim, Ranganath, Rajesh

“…In cancer research there is much interest in building and validating outcome prediction models to support treatment decisions. However, because most outcome…”
Get full text

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis by Lamba, Nayan, Muskens, Ivo S, DiRisio, Aislyn C, Meijer, Louise, Briceno, Vanessa, Edrees, Heba, Aslam, Bilal, Minhas, Sadia, Verhoeff, Joost J C, Kleynen, Catharina E, Smith, Timothy R, Mekary, Rania A, Broekman, Marike L

“…In patients with one to three brain metastases who undergo resection, options for post-operative treatments include whole-brain radiotherapy (WBRT) or…”
Get full text

Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancer by van Amsterdam, Wouter A. C., Verhoeff, Joost. J. C., Harlianto, Netanja I., Bartholomeus, Gijs A., Puli, Aahlad Manas, de Jong, Pim A., Leiner, Tim, van Lindert, Anne S. R., Eijkemans, Marinus J. C., Ranganath, Rajesh

“…Randomized Controlled Trials (RCT) are the gold standard for estimating treatment effects but some important situations in cancer care require treatment effect…”
Get full text

Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database by Kroeze, Stephanie G C, Schaule, Jana, Fritz, Corinna, Kaul, David, Blanck, Oliver, Kahl, Klaus H, Roeder, Falk, Siva, Shankar, Verhoeff, Joost J C, Adebahr, Sonja, Schymalla, Markus M, Glatzer, Markus, Szuecs, Marcella, Geier, Michael, Skazikis, Georgios, Sackerer, Irina, Lohaus, Fabian, Eckert, Franziska, Guckenberger, Matthias

“…Metastasis directed treatment (MDT) is increasingly performed with the attempt to improve outcome in non-small cell lung cancer (NSCLC) patients receiving…”
Get full text

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma by Svendsen, Agnete, Verhoeff, Joost J. C., Immervoll, Heike, Brøgger, Jan C., Kmiecik, Justyna, Poli, Aurelie, Netland, Inger A., Prestegarden, Lars, Planagumà, Jesús, Torsvik, Anja, Kjersem, Anneli Bohne, Sakariassen, Per Ø., Heggdal, Jan I., Van Furth, Wouter R., Bjerkvig, Rolf, Lund-Johansen, Morten, Enger, Per Ø., Felsberg, Joerg, Brons, Nicolaas H. C., Tronstad, Karl J., Waha, Andreas, Chekenya, Martha

“…Glioblastoma (GBM) is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival outcomes. The mechanisms of…”
Get full text

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme by Verhoeff, Joost J C, van Tellingen, Olaf, Claes, An, Stalpers, Lukas J A, van Linde, Myra E, Richel, Dirk J, Leenders, William P J, van Furth, Wouter R

“…The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM) should be considered in the unique context of malignant brain…”
Get full text

Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium by Botrugno, Carlo, Crico, Chiara, Iori, Mauro, Blanck, Oliver, Blamek, Slawomir, Postema, Pieter G., Quesada, Aurelio, Pruvot, Etienne, Verhoeff, Joost J. C., De Panfilis, Ludovica

“…This preliminary ethical appraisal from the STOPSTORM.eu consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia…”
Get full text

Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity by SOTTORIVA, Andrea, VERHOEFF, Joost J. C, BOROVSKI, Tijana, MCWEENEY, Shannon K, NAUMOV, Lev, MEDEMA, Jan Paul, SLOOT, Peter M. A, VERMEULEN, Louis

“…The recently developed concept of cancer stem cells (CSC) sheds new light on various aspects of tumor growth and progression. Here, we present a mathematical…”
Get full text

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma by Kroeze, Stephanie G.C., Fritz, Corinna, Schaule, Jana, Siva, Shankar, Kahl, Klaus H., Sundahl, Nora, Blanck, Oliver, Kaul, David, Adebahr, Sonja, Verhoeff, Joost J.C., Skazikis, Georgios, Roeder, Falk, Geier, Michael, Eckert, Franziska, Guckenberger, Matthias

“…Objectives To evaluate the safety and efficacy of stereotactic radiotherapy (SRT) in patients with metastatic renal cell carcinoma (mRCC) concurrently…”
Get full text

Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review by ter Maat, Laurens S., van Duin, Isabella A.J., Elias, Sjoerd G., van Diest, Paul J., Pluim, Josien P.W., Verhoeff, Joost J.C., de Jong, Pim A., Leiner, Tim, Veta, Mitko, Suijkerbuijk, Karijn P.M.

“…Checkpoint inhibition has radically improved the perspective for patients with metastatic cancer, but predicting who will not respond with high certainty…”
Get full text

Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer by Crockett, Cathryn B, Samson, Pamela, Chuter, Robert, Dubec, Michael, Faivre-Finn, Corinne, Green, Olga L, Hackett, Sara L, McDonald, Fiona, Robinson, Clifford, Shiarli, Anna-Maria, Straza, Michael W, Verhoeff, Joost J C, Werner-Wasik, Maria, Vlacich, Gregory, Cobben, David

“…Curative-intent radiotherapy plays an integral role in the treatment of lung cancer and therefore improving its therapeutic index is vital. MR guided…”
Get full text

Tumour control by whole brain irradiation of anti-VEGF-treated mice bearing intracerebral glioma by Verhoeff, Joost J.C, Stalpers, Lukas J.A, Claes, An, Hovinga, Koos E, Musters, Gijsbert D, Peter Vandertop, W, Richel, Dick J, Leenders, William P.J, van Furth, Wouter R

“…Abstract Aim of the study Tumour angiogenesis and invasion are key features of glioblastoma multiforme (GBM). Angiogenesis inhibitors increase progression-free…”
Get full text

Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper by Fournier, Laure, de Geus-Oei, Lioe-Fee, Regge, Daniele, Oprea-Lager, Daniela-Elena, D'Anastasi, Melvin, Bidaut, Luc, Bäuerle, Tobias, Lopci, Egesta, Cappello, Giovanni, Lecouvet, Frederic, Mayerhoefer, Marius, Kunz, Wolfgang G, Verhoeff, Joost J C, Caruso, Damiano, Smits, Marion, Hoffmann, Ralf-Thorsten, Gourtsoyianni, Sofia, Beets-Tan, Regina, Neri, Emanuele, deSouza, Nandita M, Deroose, Christophe M, Caramella, Caroline

“…Response evaluation criteria in solid tumours (RECIST) v1.1 are currently the reference standard for evaluating efficacy of therapies in patients with solid…”
Get full text

Evaluating Physiological MRI Parameters in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery—A Preliminary Analysis and Case Report by van Grinsven, Eva E., de Leeuw, Jordi, Siero, Jeroen C. W., Verhoeff, Joost J. C., van Zandvoort, Martine J. E., Cho, Junghun, Philippens, Marielle E. P., Bhogal, Alex A.

“…Brain metastases occur in ten to thirty percent of the adult cancer population. Treatment consists of different (palliative) options, including stereotactic…”
Get full text

Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors by DAMEN, PIM J.J., SUIJKERBUIJK, KARIJN P.M., VAN LINDERT, ANNE S.R., EPPINGA, WIETSE S.C., EL SHAROUNI, SHERIF Y., VERHOEFF, JOOST J.C.

“…Background/Aim: Recent studies described the safety and clinical utility of combined anti-programmed cell death protein-1 (anti-PD1) checkpoint inhibition with…”
Get full text

Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis by Bindels, Bas J J, Mercier, Carole, Gal, Roxanne, Verlaan, Jorrit-Jan, Verhoeff, Joost J C, Dirix, Piet, Ost, Piet, Kasperts, Nicolien, van der Linden, Yvette M, Verkooijen, Helena M, van der Velden, Joanne M

“…Conventional external beam radiotherapy (cEBRT) and stereotactic body radiotherapy (SBRT) are commonly used treatment options for relieving metastatic bone…”
Get full text

Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer by Nair, Shiva M., Peters, Max, Kurver, Piet, Lavi, Arnon, Verhoeff, Joost J. C., van der Voort van Zyp, Jochem R. N., van Son, Marieke J., Chin, Joseph L.

“…Background In men with recurrence of prostate cancer post radiation therapy, further treatment remains a challenge. The default salvage option of…”
Get full text

Untangling the diffusion signal using the phasor transform by Rijssel, Michael J., Froeling, Martijn, Lier, Astrid L.H.M.W., Verhoeff, Joost J.C., Pluim, Josien P.W.

“…Separating the decay signal from diffusion‐weighted scans into two or more components can be challenging. The phasor technique is well established in the field…”
Get full text

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma by van Kessel, Emma, Schuit, Ewoud, Huenges Wajer, Irene M. C., Ruis, Carla, De Vos, Filip Y. F. L., Verhoeff, Joost J. C., Seute, Tatjana, van Zandvoort, Martine J. E., Robe, Pierre A., Snijders, Tom J.

“…Background: Diffuse gliomas, which are at WHO grade II-IV, are progressive primary brain tumors with great variability in prognosis. Our aim was to investigate…”
Get full text

Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population by Lavini, Cristina, Verhoeff, Joost J.C

“…Abstract It is widely recognised that the measurement of the arterial input function (AIF) is a key issue and a major source of errors in the pharmacokinetic…”
Get full text